Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Metastatic Castration-Resistant Prostate Cancer RARITAN, N.J., ...
Abiraterone use for prostate cancer can cause mineralocorticoid excess syndrome (MES; eg, hypertension and hypokalemia). Prednisone mitigates these effects; however, the optimal dose level is unclear.
ZYTIGA(R) Plus Prednisone Demonstrates Statistically Significant Overall Survival After 49-Month Follow-Up Analysis in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate Cancer ...
This retrospective observational study confirmed a wide variability in the dosages of systemic corticosteroids for the inpatient management of AECOPD at UCH, including the use of higher dosages and ...
THE adrenal steroids have attained wide acceptance as therapeutic agents in the treatment of rheumatoid arthritis. The chemical analogue of cortisone, prednisone, has properties that have made the ...
THE treatment of acute leukemia of adults has been attended with considerable disappointment. The folic acid antagonists, although occasionally productive of well defined remissions, ordinarily have ...
Phase 3 Results Show Significant Improvement in Radiographic Progression-Free Survival and a Trend for Increased Overall Survival in Patients Receiving ZYTIGA Plus Prednisone CHICAGO, June 2, 2012 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results